- NZ$33.26m
- NZ$25.20m
- NZ$14.67m
Brief: Blis Technologies Says FY20 Revenue Guidance About NZ$10.6 Mln
Brief: Blis Technologies To Remain Operational Following Govt Lockdown
Brief: Blis Technologies Expects Full Year Revenue Of Around $10.0M
NZ's Blis Technologies sees best day in 5 months on FY forecast upgrade
NZ'S Blis Technologies rises on FY2020 forecast
Brief: Blis Technologies Sees FY 2020 Revenue In Excess Of NZ$9.4 Mln
NZ's Blis Technologies marks best session in 5 years on HY revenue jump
Brief: Blis Technologies Says HY Total Revenue NZ$5.4 Mln
NZ's Blis Technologies sees best session in 2-months; Q120 revenue up 63% Y-O-Y
Brief: Blis Technologies Says 2020 EBITDA Expected To Be In Line With Last Year
NZ's Blis Technologies: Falls as defence forces defuse chemical incident
Brief: BLIS Technologies Updates On Incident At South Dunedin Manufacturing Site
NZ defence force use controlled explosion to defuse hazardous chemical at biotech site (updated)
Defence forces on scene after chemical incident at New Zealand's Blis Technologies site
Brief: BLIS Technologies Updates On Chemical Incident At Dunedin Site
Brief: Blis Technologies Announces Health Canada Approval Of Blis M18™ Probiotic
NZ's BLIS Technologies hits 8-mth high on raised FY guidance
Brief: BLIS Technologies Upgrades FY19 Guidance
New Zealand's BLIS Technologies rises; co gets Australia nod for active drug ingredient